Research and Patient Centricity at DCB

In this podcast episode, Greta Ehlers and Dr. Stefanie Hofer from the DCB team give insights into their own lives with type 1 diabetes as well as their professional backgrounds in the diabetes field. In doing so, they specifically delve into the research we do at DCB and our strong commitment to patient centricity.

You can listen to the podcast below:

About “The Diabetic Mogul” podcast

“The Diabetic Mogul Podcast”, is hosted by Tinotenda Dzikiti (Certified Diabetes Educator) and Konstantina Taki (Medical Doctor) and who are Patient Advocates. Both Tino & Konna are co-hosting a series of podcast episodes, as they envision to inspire, empower, encourage and educate the community to prevent/manage diabetes. Their hope is that “everyone could get involved, get engaged, and come up together to create the change that this World needs.”

Learn more about DCB’s mission on ADA TV

During the American Diabetes Association’s 83rd Scientific Session, a short movie about DCB’s mission will be broadcast across the convention center and associated areas. The movie produced for ADA TV features employees as well as associated research teams of DCB and brings the mission of driving diabetes technology innovation to screens all over.

Other than on-site at the American Diabetes Association’s 83rd Scientific Sessions, it is also available to watch online:

DCB thanks the American Diabetes Association and the production company WebsEdge Medicine for this great collaboration and for giving the DCB mission a stage at the ADA congress.

• DCB Innovation, a division of the Swiss Diabetes Center Berne (DCB), has partnered with UK startup SmartStart Health to launch SmartStart CGM, the first digital support app for people with diabetes using continuous glucose monitoring (CGM) technology
• CGM is currently used by c.40% of Americans with type 1 diabetes; worldwide, nearly 50% of people with type 2 diabetes on frequent insulin injections are expected to adopt CGM by 2030[i]
• Scalable education provided by SmartStart CGM will help healthcare professionals support more patients to benefit from CGM

CGM technology constantly tracks glucose levels and can alert users when they are too high or too low. Despite proven health benefits, starting on CGM can be complex and overwhelming for people with diabetes. As many as 27% of CGM users discontinue use in the first year and up to 30% use the technology too inconsistently to benefit from it.[ii] Patients with more education regarding CGM use have better outcomes[iii] and more research is needed to create high-quality, evidence-based training and support.[iv] CGM use is expanding rapidly, creating the need for a scalable solution.

Melissa Holloway, CEO and Founder of SmartStart Health

SmartStart Health is rising to the challenge of CGM-specific patient education with SmartStart CGM, a user-friendly smartphone app. Supported by DCB, diabetes centres in the US and Switzerland will evaluate the new scalable solution in a proof-of-concept study. The partnership aims to analyse the results in Q3 2022 and publish by mid-2023.

The SmartStart CGM app is designed to inform and empower users with interactive micro-learning based on real-world scenarios that reflect the reality of living with diabetes. A telehealth portal for healthcare professionals will enable clinicians to assess patient engagement with the programme.

Dr. Thomas Grace, a diabetes specialist from Ohio, US, who will use the new CGM education app in his practice as part of the proof-of-concept study, said:

SmartStart Health Founder and CEO Melissa Holloway said:

For more information on SmartStart CGM, visit the SmartStart Health website at www.smartstart.health and subscribe to updates.

[i] https://www.healthcaredive.com/news/abbott-dexcom-diabetes-tech-type-2-jefferies/608157

[ii] Yu S et al. Diabetes Technol Ther 2018;20(6):420–427. https://doi.org/10.1089/dia.2017.0435

[iii] American Diabetes Association Professional Practice Committee; 7. Diabetes Technology: Standards of Medical Care in Diabetes—2022. Diabetes Care 1 January 2022; 45 (Supplement_1): S97–S112. https://doi.org/10.2337/dc22-S00

[iv] Heinemann L, Klonoff DC. J Diabetes Sci Technol 2020 (6):983-986. https://doi.org/10.1177/1932296819895083

About SmartStart Health

As an advocate for access to diabetes technology, Melissa Holloway identified the need for validated, scalable continuous glucose monitoring (CGM) user education through thousands of peer interactions with other people living with type 1 diabetes. With nearly 20 years of diabetes industry experience, Melissa founded SmartStart Health after participating in the 2021 DCB Open Innovation Challenge.

SmartStart Health is developing SmartStart CGM, an app-based education program to support patient onboarding and diabetes self-management with CGM. The app provides interactive mobile learning modules to empower people living with diabetes to learn about CGM and offers a telehealth portal to help healthcare teams tailor clinical care for CGM users.